Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

Yes, kidney stones can cause gastrointestinal (GI) problems, such as bloating, diarrhea, and constipation. This article ...

Mark J. Acierno, DVM, MBA, DACVIM, shares different available options for appetite stimulation and nausea relief in feline ...

Schematic representation of the aims of treatment and treatment options in the day-to-day practice for patients with chronic lymphocytic leukemia depending on their level of fitness. B ...

New treatments that could help tackle chronic pain experienced by thousands of childhood cancer survivors are being investigated by scientists in the UK. Around eight out of 10 children survive ...